Aurora Cannabis falls despite upbeat Q4 results as sales forecast weighs

Aurora Cannabis

18/06/2025 13:35

Updates

** U.S.-listed shares of pot firm Aurora Cannabis ACB.TO, ACB.O down 13.6% at $5.08 premarket

** ACB forecasts global cannabis revenue to be slightly lower in Q1 2026 vs Q4 2025 due to temporary decline in some international markets

** Posts Q4 net revenue of C$90.5 million vs est. of C$88.82 million - data compiled by LSEG

** Company reports Q4 adjusted core profit of C$16.7 million vs C$2.32 million a year ago

** Company says it found error in inventory and cost of sales from intercompany profit eliminations in financial statements for year ended March 31, 2025

** ACB adds that financial statement errors are not material to any of its previously issued financial statements

** Up till last close, stock up 38.4% YTD

 (Reporting by Pooja Menon and Sumit Saha in Bengaluru)

 ((Pooja.Menon@thomsonreuters.com;))